AGT Kit CLIA

N° du produit ABIN2943903

Détail du produit AGT Kit CLIA

Antigène: AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))

Reactivité: Humain

Méthode de détection: Chemiluminescent

Type de méthode: Competition ELISA

Gamme de detection: 12.35 pg/mL - 1000 pg/mL

Seuil minimal de détection: 12.35 pg/mL

Application: ELISA

Fonction: Human Angiotensin I CLIA Kit is a Competitive CLIA Kit for use with Serum, plasma and other biological fluids.

Type d'échantillon: Plasma, Serum

Analytical Method: Quantitative

Sensibilité: < 4.95 pg/mL

Information d'application

Indications d'application:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Stock: 4 °C/-20 °C

Stockage commentaire: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Date de péremption: 6 months

Détail du antigène

Antigène: AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))

Autre désignation: Angiotensin I (AGT Produits)

Synonymes: ANHU Kit CLIA, SERPINA8 Kit CLIA, AI265500 Kit CLIA, AngI Kit CLIA, AngII Kit CLIA, Aogen Kit CLIA, Serpina8 Kit CLIA, ANRT Kit CLIA, Ang Kit CLIA, PAT Kit CLIA, wu:fb62f06 Kit CLIA, wu:fj87b02 Kit CLIA, zgc:111892 Kit CLIA, AGT Kit CLIA, angt Kit CLIA, ANGT Kit CLIA, angiotensinogen Kit CLIA, angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Kit CLIA, AGT Kit CLIA, Agt Kit CLIA, agt Kit CLIA

Pathways: Signalistation JAK/STAT, ACE Inhibitor Pathway, EGFR Signaling Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Regulation of Lipid Metabolism by PPARalpha, Protein targeting to Nucleus, Feeding Behaviour, Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport, Positive Regulation of Response to DNA Damage Stimulus, Regulation of long-term Neuronal Synaptic Plasticity